Table 2.
Percent time allocated to clinical pediatric nephrology, research, and other activities by regiona
| n | Clinical Pediatric Nephrology | Research | Other | |
|---|---|---|---|---|
| Region | ||||
| North America | 107 | 50.0 (50.0–75.0) | 25.0 (0–25.0) | 20.0 (0–25.0) |
| Latin America | 39 | 66.7 (50.0–75.0) | 20.0 (0–28.6) | 14.3 (0–25.0) |
| Europe | 75 | 75.0 (50.0–75.0) | 25.0 (0–25.0) | 20.0 (0–25.0) |
| Asia | 59 | 50.0 (40.0–75.0) | 20.0 (0–25.0) | 25.0 (0–25.0) |
| Africa | 17 | 50.0 (50.0–75.0) | 25.0 (25.0–37.5) | 0 (0–25.0) |
| Australia/New Zealand | 15 | 75.0 (50.0–100.0) | 0 (0–25.0) | 0 (0–25.0) |
| Middle East | 26 | 75.0 (50.0–75.0) | 25.0 (16.7–25.0) | 0 (0–25.0) |
| Total | 338b | 66.7 (50.0–75.0) | 25.0 (0–25.0) | 14.3 (0–25.0) |
aValues presented as median and interquartile range (IQR)
bThree respondents who did not report their time breakdown (1 from Latin America and 2 from Asia) were excluded from the analysis